P. Chames

British Journal of Pharmacology · 2009

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom P. Chames trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. A. Lazar

Papers from P. Chames's perspective

Ordered by how strongly the researchers P. Chames trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Monoclonal antibody successes in the clinic (Nature Biotechnology)
  2. Targeting and tracing antigens in live cells with fluorescent nanobodies (Nature Methods)
  3. Engineered antibody Fc variants with enhanced effector function.
  4. FcRn: the neonatal Fc receptor comes of age
  5. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
  6. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
  7. Convergent solutions to binding at a protein-protein interface. (Science)
  8. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. (Science)
  9. The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan (Journal of Experimental Medicine)
  10. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein (Nature Biotechnology)

Their papers